CCN2: a bona fide target for anti-fibrotic drug intervention

By Leask Andrew  

Journal of Cell Communication and Signaling, Vol. 5, Iss. 2, 2011-06 ,pp. : 131-133

Springer Publishing Company

Access to resources Recommend Favorite

Antifibrotic and Anti-Inflammatory Activity of a Neuroleptic Drug on the Model of Pulmonary Fibrosis

By Dygai A.   Skurikhin E.   Andreeva T.   Pershina O.   Ermolaeva L.   Khmelevskaya E.   Krupin V.   Reztsova A.   Stepanova I.  

Bulletin of Experimental Biology and Medicine, Vol. 152, Iss. 6, 2012-04 ,pp. : 679-683

Springer Publishing Company

Access to resources Recommend Favorite

Antifibrotic Effect of Combined Treatment with Neuroleptic Drug and Immobilized Hyaluronidase in Pulmonary Fibrosis

By Dygai A.  

Bulletin of Experimental Biology and Medicine, Vol. 154, Iss. 3, 2013-01 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Design strategies for anti-amyloid agents

By Mason J.M.   Kokkoni N.   Stott K.   Doig A.J.  

Current Opinion in Structural Biology, Vol. 13, Iss. 4, 2003-08 ,pp. : 526-532

Elsevier

Access to resources Recommend Favorite

Anti-Inflammatory Intervention for Acute Liver Failure: Recent Patents and Future Targets

By  

Recent Patents on Biomarkers, Vol. 2, Iss. 2, 2012-05 ,pp. : 147-155

Bentham Science Publishers

Access to resources Recommend Favorite